Abstract
The frequent alteration of human leucocyte antigen (HLA) class I molecule expression observed in non-Hodgkin's lymphomas (NHL), similarly to solid tumours, has been reported to favour tumoral escape from the immune system. In order to identify the underlying mechanisms, we analysed 15 HLA defective NHL including partial (n = 10) and total class I (n = 5) loss, as well as HLA class II defects (n = 5). The HLA defect concerned HLA-A and -B antigens in 14 of 15 cases. In the cases with partial defect, the use of specific allelic monoclonal antibodies detected a defect of both alleles of A or B loci in six of seven tested cases. Allelic reverse transcription polymerase chain reaction (RT-PCR) demonstrated defects in six of nine cases, including four alterations of both A and B mRNA alleles. Real-time quantitative RT-PCR (RQ-PCR) did not detect the HLA-DR transcript in the two negative HLA-DR lymphomas, contrasting with the presence of CMH II transactivator (CIITA) transcript. Loss of heterozygosity (LOH) was detected in nine of 14 cases through variable pattern of nine microsatellites markers of the HLA locus. Taken together, these findings demonstrate the complexity and the variability of the mechanisms underlying HLA protein defi...Continue Reading
References
Jul 1, 1979·European Journal of Immunology·F M BrodskyP Parham
Oct 1, 1995·Immunology Today·S Ferrone, F M Marincola
Oct 1, 1993·Immunology Today·F GarridoP L Stern
Sep 1, 1996·British Journal of Cancer·J RandersonG J Morgan
Feb 1, 1997·Immunology Today·F GarridoP L Stern
Aug 29, 1997·Science·B OrtmannP Cresswell
Apr 8, 1998·British Journal of Haematology·L AmiotB Drenou
Nov 7, 1998·Immunity·S J GobinP J van den Elsen
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P JiménezF Garrido
Aug 24, 1999·Journal of Molecular Biology·R StephensS Beck
Mar 23, 2000·The Journal of Experimental Medicine·L A KoopmanG J Fleuren
Apr 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·M FeenstraM Tilanus
Jul 8, 2000·Tissue Antigens·C S BradyP L Stern
Apr 25, 2001·Genes, Chromosomes & Cancer·G RigaudA Scarpa
May 5, 2001·The American Journal of Pathology·J M HernándezJ F San Miguel
Aug 22, 2001·The Journal of Experimental Medicine·S LandmannW Reith
Dec 19, 2001·British Journal of Cancer·T StokkeH Holte
Feb 28, 2002·Blood·Jean FeuillardMarie-Christine Béné
May 2, 2002·Cell·Jenny Pan-Yun Ting, John Trowsdale
Aug 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mattias BerglundSvetlana Lagercrantz
Sep 6, 2002·The American Journal of Pathology·Sílvia BeàElias Campo
Sep 28, 2002·Blood·Roelandt F J SchopRafael Fonseca
Sep 28, 2002·Blood·Przemyslaw JuszczynskiKrzysztof Warzocha
Oct 31, 2002·British Journal of Haematology·Bernard DrénouLaurence Amiot
May 21, 2003·Immunogenetics·Ekaterina S JordanovaPhilip M Kluin
Citations
Jan 22, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M TestoniF Bertoni
Jul 12, 2013·Blood·Miguel AlcocebaMarcos González
Dec 15, 2011·Blood·Sarah T WilkinsonLisa M Rimsza
Dec 1, 2010·Blood·Andrea RinaldiFrancesco Bertoni
Apr 26, 2014·Frontiers in Immunology·Mir Munir A RahimAndrew P Makrigiannis
Jan 26, 2013·Leukemia Research·Nicolas Guillaume, Jean-Pierre Marolleau
May 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arjan DiepstraSibrand Poppema
Aug 22, 2014·Journal of Cellular Biochemistry·Faisal F Y RadwanAzizul Haque
Sep 24, 2020·Leukemia & Lymphoma·Chantana PolprasertPonlapat Rojnuckarin
Mar 2, 2017·PloS One·María García-ÁlvarezMarcos González
Apr 10, 2016·HLA : Immune Response Genetics·C RenéJ-F Eliaou
Jul 4, 2020·Cancer Discovery·Daisuke EnnishiDavid W Scott
Apr 13, 2021·Frontiers in Oncology·Benedetta ApollonioAlan G Ramsay
Apr 26, 2021·HLA : Immune Response Genetics·Chieh-Wen LoYoko Aida
Jun 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M TestoniF Bertoni